Short answer
UFP TECHNOLOGIES INC (UFPT) filed an 8-K current report with the SEC on August 3, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Q2 2026 results for the quarter ended June 30, 2026 announced on August 3, 2026.
UFP TECHNOLOGIES INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for the quarter ended June 30, 2026 announced on August 3, 2026
- Financial details and management commentary available in Exhibit 99.1, the accompanying earnings release
Item EX-99.1 · Exhibit EX-99.1
- Q2 sales $174.0M, up 15.1%, with organic growth 12.4%, signaling broad MedTech demand and contribution from acquisitions
- Net income $20.9M, up 21.4%, while diluted EPS reached $2.68 GAAP and $2.92 adjusted
- Gross margin improved to 29.3% from 28.8%, but SG&A rose to 13.1% of sales from 12.4%, limiting operating leverage
- Top five customers grew 14.7% and the broader MedTech business 19.7%, while non-medical sales were flat
- Dominican Republic investments support capacity and future costs, but near-term U.S. mix and margin pressure remain investor risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other UFP TECHNOLOGIES INC 8-K filings
Get the next UFPT 8-K as it lands
Follow UFPT for push alerts, or ask the research agent what this filing means.